--- title: "YONGDONG plans to raise no more than 365 million yuan through a private placement of shares" type: "News" locale: "en" url: "https://longbridge.com/en/news/223193816.md" description: "YONGDONG plans to raise no more than 365 million yuan by issuing A-shares to specific investors. The issuance targets no more than 35 specific investors, with the issuance price not lower than 80% of the average price of the 20 trading days prior to the pricing benchmark date. The raised funds will be used for a 2×100,000 tons per year anthracene oil deep processing project and to supplement working capital" datetime: "2024-12-24T12:07:04.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/223193816.md) - [en](https://longbridge.com/en/news/223193816.md) - [zh-HK](https://longbridge.com/zh-HK/news/223193816.md) --- # YONGDONG plans to raise no more than 365 million yuan through a private placement of shares According to the Zhitong Finance APP, YONGDONG (002753.SZ) has announced a plan for the issuance of A-shares to specific investors in 2024. The issuance will target no more than 35 specific investors (inclusive). The pricing benchmark date for this issuance will be the first day of the issuance period, and the issuance price will not be lower than 80% of the average stock price of the company over the 20 trading days prior to the pricing benchmark date (excluding the pricing benchmark date). The total amount of funds to be raised in this issuance will not exceed 365 million yuan (inclusive), and the net amount of funds raised after deducting related issuance expenses will be used entirely for the following projects: 266 million yuan for the 2×100,000 tons per year anthracene oil deep processing project; 99 million yuan for supplementing working capital ### Related Stocks - [002753.CN](https://longbridge.com/en/quote/002753.CN.md) ## Related News & Research - [Exploring Three Undiscovered Gems in the Middle East Market](https://longbridge.com/en/news/286881831.md) - [Lytix Biopharma Advances Ruxotemitide Program as Q1 2026 Results Underscore Oncology Focus](https://longbridge.com/en/news/287162474.md) - [04:00 ETEl futuro de la energía portátil: UGREEN lanza las ediciones ultradelgadas Nexode y MagFlow Air para tu día a día](https://longbridge.com/en/news/287027620.md) - [Middle East conflict hits Sri Lanka's tea industry, heightens economic strain](https://longbridge.com/en/news/287152758.md) - [Apple Flavor to Buy NovoSana’s China Assets for Up to USD66 Million in Health Supplements Push](https://longbridge.com/en/news/287039106.md)